Total Funding
78
7
Total FundingDebt Financing raised
Growth Score
-6 pts
Heat Score
-12 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
723526
NeuroSave develops devices for rapid induction of therapeutic hypothermia.
Seth T. Rodgers: CEOPast Role: Seahorse Bioscience, Chief Technology Officer- Thomas Kreck: Founder
About the Company
NeuroSave develops devices for rapid induction of therapeutic hypothermia. The company is focused on finding treatments for ischemic brain injury due to stroke, cardiac arrest, and surgery.
NeuroSave was founded in 2010 and is based in San Francisco, California.
